Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Health Clinics Limited
NKGen Biotech, Inc.
Carilion Clinic
Memorial Sloan Kettering Cancer Center
EMD Serono
The Cleveland Clinic
The University of Texas Health Science Center at San Antonio
University of Utah
University of Alabama at Birmingham
M.D. Anderson Cancer Center
AstraZeneca